What is the projected market size of the Japan Cancer Immunotherapy Market in 2024?

The Japan Cancer Immunotherapy Market is projected to be valued at 2.63 billion USD in 2024. Read More

What is the expected market size of the Japan Cancer Immunotherapy Market by 2035?

By 2035, the Japan Cancer Immunotherapy Market is expected to reach a valuation of 5.98 billion USD. Read More

What is the expected CAGR for the Japan Cancer Immunotherapy Market from 2025 to 2035?

The expected CAGR for the Japan Cancer Immunotherapy Market from 2025 to 2035 is 7.754 percent. Read More

Which therapy type holds the largest market share in 2024 within the Japan Cancer Immunotherapy Market?

In 2024, Monoclonal Antibodies hold the largest market share, valued at 1.05 billion USD. Read More

What is the market value for Check Point Inhibitors in 2024 in the Japan Cancer Immunotherapy Market?

The market value for Check Point Inhibitors in 2024 is estimated to be 0.85 billion USD. Read More

Who are the key players in the Japan Cancer Immunotherapy Market?

Key players in the Japan Cancer Immunotherapy Market include Merck & Co, Novartis, Ono Pharmaceutical, and Daiichi Sankyo. Read More

What is the growth rate for Cancer Vaccines in the Japan Cancer Immunotherapy Market from 2024 to 2035?

The market for Cancer Vaccines is expected to grow from 0.5 billion USD in 2024 to 1.05 billion USD by 2035. Read More

How much is the market for Therapeutic T-Cells expected to be valued in 2035?

The market for Therapeutic T-Cells is expected to be valued at 0.35 billion USD by 2035. Read More

What are the emerging trends in the Japan Cancer Immunotherapy Market?

Emerging trends in the Japan Cancer Immunotherapy Market include advancements in personalized medicine and combination therapies. Read More

What impact do current global trends have on the Japan Cancer Immunotherapy Market?

Current global trends are likely to influence innovation and investment in the Japan Cancer Immunotherapy Market, driving growth. Read More

Japan Cancer Immunotherapy Market

Japan Cancer Immunotherapy Market Research Report By Therapy Type (Monoclonal Antibodies, Check Point Inhibitors, Cancer Vaccines, Therapeutic T-Cells, Oncolytic Virus Therapy), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma), By End User (Hospitals, Cancer Research Institutes, Diagnostics Labs) and By Route of Administration (Intravenous, Subcutaneous, Intramuscular) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025-2035

CAGR

7.75%

2018 Market Size

$ 2.51 Billion

2035 Market Size

$ 5.98 Billion

Pharmaceutical ● Updated July 2026 Report ID: MRFR/Pharma/48385-HCR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

EXECUTIVE SUMMARY
1. Market Overview
2. Key Findings
3. Market Segmentation
4. Competitive Landscape
5. Challenges and Opportunities
6. Future Outlook
MARKET INTRODUCTION
1. Definition
2. Scope of the study
3. Research Objective
4. Assumption
5. Limitations
RESEARCH METHODOLOGY
1. Overview
2. Data Mining
3. Secondary Research
4. Primary Research
5. Primary Interviews and Information Gathering Process
6. Breakdown of Primary Respondents
7. Forecasting Model
8. Market Size Estimation
9. Bottom-Up Approach
10. Top-Down Approach
11. Data Triangulation
12. Validation
MARKET DYNAMICS
1. Overview
2. Drivers
3. Restraints
4. Opportunities
MARKET FACTOR ANALYSIS
1. Value chain Analysis
2. Porter's Five Forces Analysis
3. Bargaining Power of Suppliers
4. Bargaining Power of Buyers
5. Threat of New Entrants
6. Threat of Substitutes
7. Intensity of Rivalry
8. COVID-19 Impact Analysis
9. Market Impact Analysis
10. Regional Impact
11. Opportunity and Threat Analysis
Japan Cancer Immunotherapy Market, BY Therapy Type (USD Billion)
1. Monoclonal Antibodies
2. Check Point Inhibitors
3. Cancer Vaccines
4. Therapeutic T-Cells
5. Oncolytic Virus Therapy
Japan Cancer Immunotherapy Market, BY Cancer Type (USD Billion)
1. Breast Cancer
2. Lung Cancer
3. Colorectal Cancer
4. Prostate Cancer
5. Melanoma
Japan Cancer Immunotherapy Market, BY End User (USD Billion)
1. Hospitals
2. Cancer Research Institutes
3. Diagnostics Labs
Japan Cancer Immunotherapy Market, BY Route of Administration (USD Billion)
1. Intravenous
2. Subcutaneous
3. Intramuscular
4. Competitive Landscape
5. Overview
6. Competitive Analysis
7. Market share Analysis
8. Major Growth Strategy in the Cancer Immunotherapy Market
9. Competitive Benchmarking
10. Leading Players in Terms of Number of Developments in the Cancer Immunotherapy Market
11. Key developments and growth strategies
12. New Product Launch/Service Deployment
13. Merger & Acquisitions
14. Joint Ventures
15. Major Players Financial Matrix
16. Sales and Operating Income
17. Major Players R&D Expenditure. 2023
18. Company Profiles
19. Merck & Co
20. Financial Overview
21. Products Offered
22. Key Developments
23. SWOT Analysis
24. Key Strategies
25. Novartis
26. Financial Overview
27. Products Offered
28. Key Developments
29. SWOT Analysis
30. Key Strategies
31. Ono Pharmaceutical
32. Financial Overview
33. Products Offered
34. Key Developments
35. SWOT Analysis
36. Key Strategies
37. Daiichi Sankyo
38. Financial Overview
39. Products Offered
40. Key Developments
41. SWOT Analysis
42. Key Strategies
43. Mitsubishi Tanabe Pharma
44. Financial Overview
45. Products Offered
46. Key Developments
47. SWOT Analysis
48. Key Strategies
49. Kite Pharma
50. Financial Overview
51. Products Offered
52. Key Developments
53. SWOT Analysis
54. Key Strategies
55. Roche
56. Financial Overview
57. Products Offered
58. Key Developments
59. SWOT Analysis
60. Key Strategies
61. Eisai
62. Financial Overview
63. Products Offered
64. Key Developments
65. SWOT Analysis
66. Key Strategies
67. Chugai Pharmaceutical
68. Financial Overview
69. Products Offered
70. Key Developments
71. SWOT Analysis
72. Key Strategies
73. Amgen
74. Financial Overview
75. Products Offered
76. Key Developments
77. SWOT Analysis
78. Key Strategies
79. Takeda Pharmaceutical
80. Financial Overview
81. Products Offered
82. Key Developments
83. SWOT Analysis
84. Key Strategies
85. Astellas Pharma
86. Financial Overview
87. Products Offered
88. Key Developments
89. SWOT Analysis
90. Key Strategies
91. Pfizer
92. Financial Overview
93. Products Offered
94. Key Developments
95. SWOT Analysis
96. Key Strategies
97. BristolMyers Squibb
98. Financial Overview
99. Products Offered
100. Key Developments
101. SWOT Analysis
102. Key Strategies
103. Appendix
104. References
105. Related Reports
106. LIST Of tables
LIST OF ASSUMPTIONS
Japan Cancer Immunotherapy Market SIZE ESTIMATES & Japan Cancer Immunotherapy Market, BY THERAPY TYPE, 2019-2035 (USD Billions)
Japan Cancer Immunotherapy Market SIZE ESTIMATES & Japan Cancer Immunotherapy Market, BY CANCER TYPE, 2019-2035 (USD Billions)
Japan Cancer Immunotherapy Market SIZE ESTIMATES & Japan Cancer Immunotherapy Market, BY END USER, 2019-2035 (USD Billions)
Japan Cancer Immunotherapy Market SIZE ESTIMATES & Japan Cancer Immunotherapy Market, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)
1. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
2. ACQUISITION/PARTNERSHIP
3. LIST Of figures
MARKET SYNOPSIS
1. JAPAN CANCER IMMUNOTHERAPY MARKET ANALYSIS BY THERAPY TYPE
2. JAPAN CANCER IMMUNOTHERAPY MARKET ANALYSIS BY CANCER TYPE
3. JAPAN CANCER IMMUNOTHERAPY MARKET ANALYSIS BY END USER
4. JAPAN CANCER IMMUNOTHERAPY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
KEY BUYING CRITERIA OF CANCER IMMUNOTHERAPY MARKET
1. RESEARCH PROCESS OF MRFR
DRO ANALYSIS OF CANCER IMMUNOTHERAPY MARKET
1. DRIVERS IMPACT ANALYSIS: CANCER IMMUNOTHERAPY MARKET
2. RESTRAINTS IMPACT ANALYSIS: CANCER IMMUNOTHERAPY MARKET
3. SUPPLY / VALUE CHAIN: CANCER IMMUNOTHERAPY MARKET
Japan Cancer Immunotherapy Market, BY THERAPY TYPE, 2025 (% SHARE)
Japan Cancer Immunotherapy Market, BY THERAPY TYPE, 2019 TO 2035 (USD Billions)
Japan Cancer Immunotherapy Market, BY CANCER TYPE, 2025 (% SHARE)
Japan Cancer Immunotherapy Market, BY CANCER TYPE, 2019 TO 2035 (USD Billions)
Japan Cancer Immunotherapy Market, BY END USER, 2025 (% SHARE)
Japan Cancer Immunotherapy Market, BY END USER, 2019 TO 2035 (USD Billions)
Japan Cancer Immunotherapy Market, BY ROUTE OF ADMINISTRATION, 2025 (% SHARE)
Japan Cancer Immunotherapy Market, BY ROUTE OF ADMINISTRATION, 2019 TO 2035 (USD Billions)
1. BENCHMARKING OF MAJOR COMPETITORS

Certified Researchers

Customize Report

Japan Cancer Immunotherapy Market Segmentation

Japan Cancer Immunotherapy Market By Therapy Type (USD Billion, 2019-2035)
- Monoclonal Antibodies
- Check Point Inhibitors
- Cancer Vaccines
- Therapeutic T-Cells
- Oncolytic Virus Therapy

Japan Cancer Immunotherapy Market By Cancer Type (USD Billion, 2019-2035)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma

Japan Cancer Immunotherapy Market By End User (USD Billion, 2019-2035)
- Hospitals
- Cancer Research Institutes
- Diagnostics Labs

Japan Cancer Immunotherapy Market By Route of Administration (USD Billion, 2019-2035)
- Intravenous
- Subcutaneous
- Intramuscular

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”